Loading stock data...

Nexus Surgical & Medicare Ltd.

BSE: NEXUSSURGL

BSE
18.00 0.05 (0.28%)

Prev Close

17.95

Open Price

17.95

Volume

6,169

Today Low / High

17.95 / 18

52 WK Low / High

13.8 / 29.28

Range

17 - 19

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 18, reflecting a change of 0.05 (0.27855%). The expected target range on the BSE is 17 - 19. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

22 Aug 17.95 0.28%
21 Aug 18.15 -1.10%
20 Aug 17.01 6.70%
19 Aug 15.53 9.53%
18 Aug 16.21 13.51%
14 Aug 18.80 -13.78%
13 Aug 17.02 10.63%
12 Aug 17.08 -0.41%
11 Aug 18.00 -5.56%
08 Aug 17.45 -11.17%
07 Aug 17.15 -0.47%
06 Aug 16.93 1.18%
05 Aug 17.00 -0.47%
04 Aug 17.00 -0.29%
01 Aug 16.65 2.10%
31 Jul 17.79 -4.44%
30 Jul 16.52 -0.48%
29 Jul 16.50 0.12%
28 Jul 16.23 1.66%

Nexus Surgical & Medicare Ltd. Graph

Nexus Surgical & Medicare Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Nexus Surgical & Medicare Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 18.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 18.00 18.18 16.36 - 20.00
18.36 14.69 - 22.03
18.54 12.98 - 24.10
Bearish Scenario 18.00 17.82 16.04 - 19.60
17.64 14.11 - 21.17
17.46 12.22 - 22.70

Overview of Nexus Surgical & Medicare Ltd.

ISIN

INE370Q01015

Industry

Medical - Distribution

Vol.Avg

3,770

Market Cap

98,494,200

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

-43.96

DCF

66

Financial Ratios Every Investor Needs

Stock Rating Details for NEXUSSURGL

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 5 Strong Buy
ROE Score 5 Strong Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 5.72 Cr 2.28 Cr 3.44 Cr 0.6018 0.00 Cr 0.00 Cr 0.66 Cr 0.50 Cr 0.92 0.66 Cr 0.0869
2024-03-31 3.47 Cr 0.84 Cr 2.64 Cr 0.7595 0.00 Cr 1.91 Cr 0.29 Cr 0.21 Cr 0.39 0.29 Cr 0.0614
2023-03-31 1.55 Cr 0.71 Cr 0.85 Cr 0.5459 0.00 Cr 0.38 Cr 0.22 Cr 0.17 Cr 0.31 0.22 Cr 0.1099
2022-03-31 2.40 Cr 0.23 Cr 2.17 Cr 0.9055 0.00 Cr 1.65 Cr 0.37 Cr 0.29 Cr 0.53 0.37 Cr 0.1212
2021-03-31 3.74 Cr 1.35 Cr 2.40 Cr 0.6404 0.00 Cr 0.81 Cr 0.16 Cr 0.15 Cr 0.28 0.16 Cr 0.0411

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.33 Cr 2.27 Cr 1.21 Cr 1.0636 Cr 0.00 Cr -0.33 Cr 0.43 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.2109 Cr
2024-03-31 0.23 Cr 1.81 Cr 1.24 Cr 0.5663 Cr 0.00 Cr -0.23 Cr 0.40 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.2400 Cr
2023-03-31 0.35 Cr 0.92 Cr 0.56 Cr 0.3529 Cr 0.00 Cr -0.35 Cr 0.10 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.5626 Cr
2022-03-31 0.11 Cr 2.00 Cr 1.82 Cr 0.1822 Cr 0.00 Cr -0.11 Cr 0.43 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.8215 Cr
2021-03-31 0.22 Cr 0.93 Cr 1.04 Cr -0.1080 Cr 0.00 Cr -0.22 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.0430 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.1032 Cr -0.0071 Cr 0.0000 Cr 0.0961 Cr 0.0000 Cr 0.3313 Cr -0.0071 Cr 0.4974 Cr 0.0000 Cr 0.0000 Cr -0.0266 Cr
2024-03-31 -0.4140 Cr -0.0030 Cr 0.0000 Cr -0.4170 Cr -0.0042 Cr 0.0023 Cr -0.0030 Cr 0.2133 Cr 0.0000 Cr 0.0000 Cr -0.3315 Cr
2023-03-31 0.5497 Cr -0.0063 Cr 0.0000 Cr 0.5433 Cr 0.0054 Cr 0.0065 Cr -0.0063 Cr 0.1707 Cr 0.0000 Cr 0.0000 Cr 0.0035 Cr
2022-03-31 -0.1106 Cr -0.0011 Cr 0.0000 Cr -0.1117 Cr -0.1117 Cr 0.0011 Cr -0.0011 Cr 0.2902 Cr 0.0000 Cr 0.0000 Cr -0.4257 Cr
2021-03-31 0.1986 Cr 0.0000 Cr 0.0000 Cr 0.1986 Cr 0.1986 Cr 0.2195 Cr 0.0000 Cr 0.1704 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 1.48 Cr 0.91 Cr 0.57 Cr 0.3866 0.11 Cr 0.09 Cr 0.16 0.11 Cr 0.0596
2024-12-31 1.48 Cr 0.34 Cr 1.14 Cr 0.7690 0.15 Cr 0.11 Cr 0.21 0.15 Cr 0.0766
2024-09-30 0.99 Cr 0.42 Cr 0.58 Cr 0.5822 0.28 Cr 0.21 Cr 0.38 0.28 Cr 0.2067
2024-06-30 1.76 Cr 0.61 Cr 1.15 Cr 0.6527 0.12 Cr 0.09 Cr 0.16 0.12 Cr 0.0511
2024-03-31 0.60 Cr 0.28 Cr 0.32 Cr 0.5391 0.09 Cr 0.06 Cr 0.11 0.12 Cr 0.0977

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.33 Cr 0.04 Cr 0.37 Cr 1.34 Cr 0.43 Cr 2.24 Cr 0.02 Cr 2.27 Cr 1.21 Cr
2024-09-30 0.08 Cr 0.04 Cr 0.12 Cr 1.46 Cr 0.32 Cr 2.01 Cr 0.03 Cr 2.05 Cr 1.18 Cr
2024-03-31 0.23 Cr 0.00 Cr 0.23 Cr 0.86 Cr 0.50 Cr 1.75 Cr 0.02 Cr 1.81 Cr 1.24 Cr
2023-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 0.66 Cr 0.15 Cr 0.66 Cr 0.31 Cr 0.20 Cr 1.33 Cr 0.02 Cr 1.39 Cr 0.93 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 0.05 Cr 0.05 Cr 0.00 Cr 0.00 Cr -0.62 Cr 0.05 Cr 0.66 Cr 0.00 Cr 0.05 Cr
2023-09-30 0.08 Cr 0.08 Cr 0.00 Cr 0.00 Cr 0.08 Cr 0.66 Cr 0.58 Cr 0.00 Cr 0.08 Cr
2023-06-30 0.03 Cr 0.03 Cr 0.00 Cr 0.00 Cr -0.32 Cr 0.03 Cr 0.35 Cr 0.00 Cr 0.03 Cr
2023-03-31 -0.10 Cr -0.10 Cr 0.00 Cr 0.00 Cr -0.10 Cr 0.35 Cr 0.45 Cr 0.00 Cr -0.10 Cr
2022-12-31 0.14 Cr 0.14 Cr 0.00 Cr 0.00 Cr -0.25 Cr 0.14 Cr 0.39 Cr 0.00 Cr 0.14 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Distribution

No stocks found in this industry.

Key Executives

Company Secretary & Compliance Officer
Ms. Monika Choudhary

Gender: female

Year Born:

Chief Financial Officer & Executive Director
Mr. Pawankumar Sitaram Choudhary

Gender: male

Year Born: 1955

Chairman & MD
Mr. Ram Swaroop Mahadev Joshi B.Com.

Gender: male

Year Born: 1961

FAQs about Nexus Surgical & Medicare Ltd.

Who is the CEO of the company?

The CEO is Ram Swaroop Mahadev Joshi.

What is the current market price of the stock?

The current price is ₹18.00.

What is the 52-week price range?

The range is ₹13.8-29.28.

What is the market capitalization of the company?

The market capitalization is ₹9.85 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 19.58.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Nexus Surgical & Medicare Ltd. (ISIN: INE370Q01015) is a leading Medical - Distribution in India. With a market capitalization of ₹9.85 crores and an average daily volume of 3,770 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack